Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 64

Sort by

Sort Order Select

Journal Articles

Fludarabine Melphalan Versus Fludarabine Treosulfan As Reduced Intensity Conditioning Regimens in Allogeneic Hematopoietic Stem Cell Transplant - a Retrospective Analysis

Akanksha Chichra, DNB, Lingaraj Nayak, MDDM MDcal Oncology, Rushabh Kothari, MD DM MDcal Oncology, Siddhesh Arun Kalantri, MD, Avinash Bonda, MD DM, Anant Gokarn, MD, Sachin Punatar, MBBS,MDDM MDcal Oncology, Bhausaheb Bagal, MD DM, Sadhana Kannan, MSc, Libin J Mathew, Navin Khattry, MD DM MDcal Oncology

Blood (2019) 134 (Supplement_1): 4493.

https://doi.org/10.1182/blood-2019-128099

Published: 2019

Journal Articles

Proton Pump Inhibitors Associated with Higher Incidence of Mucositis in Patients Receiving Methotrexate for Graft Vs Host Disease Prophylaxis

Luke Mountjoy, DO, Daniel Almquist, MD, Henry Ofori, Pharm D, RPh, Marlene Girardo, MS, Margaret McCallen, Pharm D, RPh

Blood (2019) 134 (Supplement_1): 3262.

https://doi.org/10.1182/blood-2019-128644

Published: 2019

Journal Articles

Copper Deficiency and Cytopenia: A Systematic Review

Prakash Kharel, MD, Karthik Gnanapandithan, MD MS, Ramesh Kumar Pandey, MD, Samir Jha, Alyssa Grimshaw, MSLIS, Smith Giri, MBBS

Blood (2019) 134 (Supplement_1): 5025.

https://doi.org/10.1182/blood-2019-132265

Published: 2019

Journal Articles

Predictors of Mortality in Neutropenic Enterocolitis Among Children and Young Adults with Acute Myeloid Leukemia in Low Middle Income Countries

Reham Khedr, MD, Mohamed Abdel Waged, Marwa Fathy, MD, Wael Zekri, MD

Blood (2018) 132 (Supplement 1): 5174.

https://doi.org/10.1182/blood-2018-99-114970

Published: 2018

Journal Articles

Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis in Myeloablative Allogeneic Hematopoietic Transplantation Shortens the Duration of Mucositis and Hospitalization

Craig W. Freyer, PharmD, Alex Ganetsky, PharmD, Colleen Timlin, PharmD, Daria V. Babushok, MD PhD, Noelle V. Frey, MD, Saar I. Gill, MD PhD, Elizabeth O. Hexner, MD MS, Alison W. Loren, MD MS, James K. Mangan, MD PhD, Mary Ellen Martin, MD, Shannon R. McCurdy, MD, Alexander E. Perl, MD, Selina Luger, MD, Jacqueline Smith, MSN, CRNP, Edward Stadtmauer, David L. Porter, MD

Blood (2018) 132 (Supplement 1): 5696.

https://doi.org/10.1182/blood-2018-99-111550

Published: 2018

Journal Articles

Pre-Transplant Hemoglobin and Creatinine Clearance Correlate with Treatment Free Survival in Patients with Myeloma Receiving Mel200 and Autologous Stem Cell Transplantation

Karen Sweiss, PharmD, Gregory Sampang Calip, PharmD, MPH, PhD, Jeremy Johnson, PharmD, PhD, Hyunyoung Jeong, PharmD, PhD, Damiano Rondelli, MD, Pritesh Patel, MD

Blood (2018) 132 (Supplement 1): 4621.

https://doi.org/10.1182/blood-2018-99-117623

Published: 2018

Journal Articles

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Jeremy Pappacena, PharmD, Valkal Bhatt, PharmD, BCOP, BCPS, Gunjan L. Shah, MD, Patrick Hilden, MS, Molly Maloy, MS, Larry W Buie, PharmD, BCOP, FASHP, Sergio A. Giralt, MD, Michael Scordo, MD

Blood (2017) 130 (Supplement 1): 1950.

https://doi.org/10.1182/blood.V130.Suppl_1.1950.1950

Published: 2017

Journal Articles

Impact of Carmustine (BCNU) Substitution for Bendamustine in the Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation for the Treatment of Lymphoma

Josie-Anne Boisjoly, MD, Philippe Bouchard, BPharm, Sandra Cohen, MD FRCP(C), Imran Ahmad, MD, Nadia M. Bambace, MD, Léa Bernard, MD, Jean-Sébastien Delisle, MD PhD, Thomas L Kiss, MD, Denis-Claude Roy, MD, Guy Sauvageau, MD, PhD, Jean Roy, MD, Silvy Lachance, MDFRCPC

Blood (2017) 130 (Supplement 1): 2022.

https://doi.org/10.1182/blood.V130.Suppl_1.2022.2022

Published: 2017

Journal Articles

Comparison of Frontline Induction Therapy Using Idarubicin in Combination with High-Dose (HDAC3) Versus Intermediate-Dose Cytarabine (IDAC3) in Adult Acute Myeloid Leukemia

Ing Soo S Tiong, MBBS, Katherine Fielding, MBBS, BMedSci, Chun Y Fong, MBBS, BMedSci, FRACP,FRCPA, Hadley Bortz, BPharm, GradCert PharmPrac, MClinPharm, MSHP, Sharon Avery, MBBS, FRACP, FRCPA, Andrew P Grigg, MBBS, MD FRACP, FRCPA, Andrew Wei, MBBS, PhD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 3868.

https://doi.org/10.1182/blood.V130.Suppl_1.3868.3868

Published: 2017

Journal Articles

In-Hospital Mortality and Cost of Allogeneic Hematopoietic Cell Transplant (HCT) in Adult Acute Myeloid Leukemia: National Inpatient Sample (NIS) Years 2002-2013

Urshila Durani, MD MPH, Ronald S Go, MD, Ankit Kansagra, MD, Hassan B. Alkhateeb, MD, Mark R. Litzow, MD, William J. Hogan, MBBCh

Blood (2017) 130 (Supplement 1): 4690.

https://doi.org/10.1182/blood.V130.Suppl_1.4690.4690

Published: 2017

Journal Articles

The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era

Marla M. Jalbut, MD, Evan C. Chen, MD, Gabriela S. Hobbs, MD, Ashley M. Perry, BS, Lillian Werner, MS, Philip C. Amrein, MD, Amir T. Fathi, MD MD BS, Andrew M. Brunner, MD

Blood (2017) 130 (Supplement 1): 2586.

https://doi.org/10.1182/blood.V130.Suppl_1.2586.2586

Published: 2017

Journal Articles

Anti α4β7 Integrin Monoclonal Antibody (Vedolizumab) for the Treatment of Steroid-Resistant Severe Intestinal Acute Graft Versus Host Disease

Ivetta Danylesko, Roni Shouval, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Arie Apel, MD, Avichai Shimoni, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 3263.

https://doi.org/10.1182/blood.V130.Suppl_1.3263.3263

Published: 2017

Journal Articles

Economic Burden of Veno-Occlusive Disease (VOD) in Patients with Acute Lymphoblastic Leukemia (ALL) in the US

Xinke Zhang, PhD, Xue Song, PhD, Lorena Lopez-Gonzalez, PhD, Krutika Jariwala-Parikh, PhD, Vadim Romanov, MD Mphil, FFPM, Ze Cong, PhD

Blood (2017) 130 (Supplement 1): 5611.

https://doi.org/10.1182/blood.V130.Suppl_1.5611.5611

Published: 2017

Journal Articles

Optimizing Autologous Stem Cell Transplant for High-Risk Patients with Plasma Cell Dyscrasias

Naveed Ali, MD, Brenda W. Cooper, MD, Merle Kolk, Richard Creger, PhD, Gina Hoffman, Hillard M Lazarus, MD, Ben K. Tomlinson, MD, Paolo Caimi, MD, Leland Metheny, MD, Marcos de Lima, MD, Ehsan Malek, MD

Blood (2017) 130 (Supplement 1): 5656.

https://doi.org/10.1182/blood.V130.Suppl_1.5656.5656

Published: 2017

Journal Articles

Determinants for Oral Mucositis in Allogeneic Hematopoietic Stem Cell Transplantation: Prospective Evaluation and Risk Analysis

Roni Shouval, Liza Kouniavsky, Joshua Fein, Ivetta Danylesko, Arie Apel, MD, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 3239.

https://doi.org/10.1182/blood.V130.Suppl_1.3239.3239

Published: 2017

Journal Articles

Malyglycemia Is Associated with Increased Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients

Jenna Sopfe, MD, Amy Keating, MD, Laura Pyle, PhD, Arthur K Liu, MD, Paul Wadwa, MD, Roger Giller, MD, Gregory Forlenza, MD MS, Michael R Verneris, MD

Blood (2017) 130 (Supplement 1): 3243.

https://doi.org/10.1182/blood.V130.Suppl_1.3243.3243

Published: 2017

Journal Articles

Non-Cryopreserved Autologous Hematopoietic Transplantation Has Less Short Term Complications, Faster Engraftment and Similar Transplant Outcomes Than Cryopreserved Modality in Multiple Myeloma and Lymphoma Patients. a Comparative Analysis of Two Centers

Mauricio Sarmiento, MD, Rocio Parody, MD PhD, Queralt Salas, MD, Nicole Beffermann, MD, Veronica Jara, RN, Pablo A Bertin, MD, Isabel Sánchez-Ortega, MD PhD, Pablo Ramirez, MD, Mauricio Ocqueteau, MD, Beatriz Patiño, NG, Anna Sureda, MD PhD

Blood (2016) 128 (22): 2261.

https://doi.org/10.1182/blood.V128.22.2261.2261

Published: 2016

Journal Articles

Hospital Volume Does Not Influence in-Hospital Mortality of Autologous Hematopoietic Cell Transplant Among Multiple Myeloma Patients in the United States

Smith Giri, MBBS, Prajwal Dhakal, MBBS, Kathan Dilipbhai Mehta, MBBS, MPH, Vijaya R. Bhatt, MD

Blood (2016) 128 (22): 392.

https://doi.org/10.1182/blood.V128.22.392.392

Published: 2016

Journal Articles

Tigecycline-Based Front-Line Antibiotic Therapy Significantly Decreases Mortality Among Patients with Neutropenic Enterocolitis Following Cytarabine-Containing Chemotherapy for the Remission Induction of Acute Myeloid Leukemia

Pugliese Novella, Paola Salvatore, MD, Dora Vita Iula, MD, Maria Rosaria Catania, MD, Federico Chiurazzi, MD, Marta Raimondo, Giuliana Beneduce, Claudio Cerchione, Roberta Della Pepa, Claudia Giordano, MD, Luigia Simeone, MD, Fabrizio Pane, MD, Marco Picardi

Blood (2016) 128 (22): 3550.

https://doi.org/10.1182/blood.V128.22.3550.3550

Published: 2016

Journal Articles

Haemopoietic Stem Cell Transplantation for Diamond Blackfan Anaemia Leads to Early and Sustained Engraftment with Good Long-Term Outcomes, but Has an Increased Risk of Gut Toxicity and Lung GvHD

Farah O'Boyle, PhD, Anne Bradshaw, Richard M Szydlo, Josu de la Fuente, PhD FRCP, FRCPI, FRCPCH, FRCPath

Blood (2016) 128 (22): 2679.

https://doi.org/10.1182/blood.V128.22.2679.2679

Published: 2016

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Fludarabine Melphalan Versus Fludarabine Treosulfan As Reduced Intensity Conditioning Regimens in Allogeneic Hematopoietic Stem Cell Transplant - a Retrospective Analysis

Proton Pump Inhibitors Associated with Higher Incidence of Mucositis in Patients Receiving Methotrexate for Graft Vs Host Disease Prophylaxis

Copper Deficiency and Cytopenia: A Systematic Review

Predictors of Mortality in Neutropenic Enterocolitis Among Children and Young Adults with Acute Myeloid Leukemia in Low Middle Income Countries

Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis in Myeloablative Allogeneic Hematopoietic Transplantation Shortens the Duration of Mucositis and Hospitalization

Pre-Transplant Hemoglobin and Creatinine Clearance Correlate with Treatment Free Survival in Patients with Myeloma Receiving Mel200 and Autologous Stem Cell Transplantation

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Impact of Carmustine (BCNU) Substitution for Bendamustine in the Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation for the Treatment of Lymphoma

Comparison of Frontline Induction Therapy Using Idarubicin in Combination with High-Dose (HDAC3) Versus Intermediate-Dose Cytarabine (IDAC3) in Adult Acute Myeloid Leukemia

In-Hospital Mortality and Cost of Allogeneic Hematopoietic Cell Transplant (HCT) in Adult Acute Myeloid Leukemia: National Inpatient Sample (NIS) Years 2002-2013

The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era

Anti α4β7 Integrin Monoclonal Antibody (Vedolizumab) for the Treatment of Steroid-Resistant Severe Intestinal Acute Graft Versus Host Disease

Economic Burden of Veno-Occlusive Disease (VOD) in Patients with Acute Lymphoblastic Leukemia (ALL) in the US

Optimizing Autologous Stem Cell Transplant for High-Risk Patients with Plasma Cell Dyscrasias

Determinants for Oral Mucositis in Allogeneic Hematopoietic Stem Cell Transplantation: Prospective Evaluation and Risk Analysis

Malyglycemia Is Associated with Increased Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients

Non-Cryopreserved Autologous Hematopoietic Transplantation Has Less Short Term Complications, Faster Engraftment and Similar Transplant Outcomes Than Cryopreserved Modality in Multiple Myeloma and Lymphoma Patients. a Comparative Analysis of Two Centers

Hospital Volume Does Not Influence in-Hospital Mortality of Autologous Hematopoietic Cell Transplant Among Multiple Myeloma Patients in the United States

Tigecycline-Based Front-Line Antibiotic Therapy Significantly Decreases Mortality Among Patients with Neutropenic Enterocolitis Following Cytarabine-Containing Chemotherapy for the Remission Induction of Acute Myeloid Leukemia

Haemopoietic Stem Cell Transplantation for Diamond Blackfan Anaemia Leads to Early and Sustained Engraftment with Good Long-Term Outcomes, but Has an Increased Risk of Gut Toxicity and Lung GvHD

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only